Clinical trial
Biological Therapy in Treating Patients With Prostate Cancer
NCT00039299 · Jonsson Comprehensive Cancer Center, Other · Completed
Key facts
| NCT number | NCT00039299 |
|---|---|
| Title | Biological Therapy in Treating Patients With Prostate Cancer |
| Official title | A Phase I Safety Study Of Xcellerate In Patients With Hormone Refractory Prostate Cancer |
| Lead sponsor | Jonsson Comprehensive Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Biological |
| Interventions | therapeutic autologous lymphocytes |
| Start date | Mar 1, 2002 |
| Completion | Jun 1, 2003 |
| First posted | Jan 27, 2003 |
| Last update posted | Apr 4, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: